4 active
/
14 total (since 2015)
0
Phase 1 Active
0 total
0
Phase 2 Active
3 total
1
Phase 3 Active
3 total
3
Phase 4 Active
9 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
No industry sponsors with active trials
NCT02814916 COMPLETED
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
AbbVie n=199
NCT03556917 COMPLETED
The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy.
Universidade Norte do Paraná n=30
Data: ClinicalTrials.gov